Prospective study of risk factors of relapse after treatment of acne with oral isotretinoin

Dermatology

Volumn 212, Issue 2, 2006, Pages 168-176

  Quereux G ^a   Volteau, C ^b   N'Guyen, J M ^b   Dreno B ^a,c  

^a NANTES UNIVERSITY HOSPITAL   (France)

^b Clinical Pharmacology Department   (France)

^c HÔTEL DIEU   (France)

Author keywords

Acne relapse; Isotretinoin stop

Indexed keywords

ADAPALENE; AMINOTRANSFERASE; BENZOYL PEROXIDE; CHOLESTEROL; CYCLINE; CYPROTERONE ACETATE; DIANE; ERYTHROMYCIN; GLUCONATE ZINC; ISOTRETINOIN; RETINOIC ACID; TRIACYLGLYCEROL;

ABNORMALLY HIGH SUBSTRATE CONCENTRATION IN BLOOD; ACNE; ADOLESCENT; ADULT; AMINOTRANSFERASE BLOOD LEVEL; ARTHRALGIA; ARTICLE; CHEILITIS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DISEASE SEVERITY; DRY SKIN; ECZEMA; EPISTAXIS; ERYTHEMA; EYE IRRITATION; FAMILY HISTORY; FEMALE; FOLLOW UP; GASTRITIS; GROUPS BY AGE; HEADACHE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTRIGLYCERIDEMIA; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; MYALGIA; OPEN STUDY; PHOTOTOXICITY; PREPUBERTY; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; PRURITUS; RELAPSE; RISK; RISK FACTOR; SEBORRHEA; TREATMENT OUTCOME; TREATMENT WITHDRAWAL; TRIACYLGLYCEROL BLOOD LEVEL; TRUNK; UNIVERSITY HOSPITAL; XEROSIS;

ACNE VULGARIS; ADMINISTRATION, ORAL; ADOLESCENT; ADULT; CHILD; FEMALE; FOLLOW-UP STUDIES; HUMANS; ISOTRETINOIN; MALE; PROSPECTIVE STUDIES; RECURRENCE; RISK FACTORS; TREATMENT OUTCOME;

EID: 32944465140     PISSN: 10188665     EISSN: None     Source Type: Journal    
DOI: 10.1159/000090658     Document Type: Article

References (19)

1. Layton AM, Knaggs H, Taylor J, Cunliffe WJ: Isotretinoin for acne vulgaris - 10 years later: a safe and successful treatment. Br J Dermatol 1993;129:292-296.
2. Cunliffe WJ, van de Kerkhof PC, Caputo R, Cavicchini S, Cooper A, Fyrand OL, Gollnick H, Layton AM, Leyden JJ, Mascaro JM, Ortonne JP, Shalita A: Roaccutane treatment guidelines: results of an international survey. Dermatology 1997;194:351-357.
3. Hull PR, Demkiw-Bartel C: Isotretinoin use in acne: prospective evaluation of adverse events. J Cutan Med Surg 2000;4:66-70.
4. Bigby M, Stern RS: Adverse reactions to isotretinoin. A report from the Adverse Drug Reaction Reporting System. J Am Acad Dermatol 1988;18:543-552.
5. Strauss JS, Rapini RP, Shalita AR, Konecky E, Pochi PE, Comite H, Exmer JH: Isotretinoin therapy for acne: results of a multicenter dose-response study. J Am Acad Dermatol 1984;10:490-496.
6. Cunliffe WJ, Norris JF: Isotretinoin - An explanation for its long-term benefit. Dermatologica 1987;175(suppl 1):133-137.
7. Chivot M, Midoun H: Isotretinoin and acne: a study of relapses. Dermatologica 1990;180:240-243.
8. Stainforth JM, Layton AM, Taylor JP, Cunliffe WJ: Isotretinoin for the treatment of acne vulgaris: which factors may predict the need for more than one course? Br J Dermatol 1993;129:297-301.
9. Falk ES, Stenvold SE: Long-term effects of isotretinoin in the treatment of severe nodulocystic acne. Riv Eur Sci Med Farmacol 1992;14:215-220.
10. Lehucher-Ceyrac D, Weber-Buisset MJ: Isotretinoin and acne in practice: a prospective analysis of 188 cases over 9 years. Dermatology 1993;186:123-128.
11. Lehucher-Ceyrac D, de La Salmonière P, Chastang C, Morel P: Predictive factors for failure of isotretinoin treatment in acne patients: results from a cohort of 237 patients. Dermatology 1999;198:278-283.
12. Ng PP, Goh CL: Treatment outcome of acne vulgaris with oral isotretinoin in 89 patients. Int J Dermatol 1999;38:213-216.
13. Dréno B, Bodokh I, Chivot M, Daniel F, Humbert P, Poli F, Clerson P, Berrou JP: ECLA grading: a system of acne classification for everyday dermatological practice. Ann Dermatol Vénéréol 1999;126:136-141.
14. Burke BM, Cunliffe WJ: The assessment of acne vulgaris - The Leeds technique. Br J Dermatol 1984;111:83-92.
15. Hermes B, Praetel C, Henz BM: Medium dose isotretinoin for the treatment of acne. J Eur Acad Dermatol Venereol 1998;11:117-121.
16. Harms M, Duvanel T, Williamson C, Masouyé I, Saurat JH: Isotretinoin therapy for acne: should we consider the total cumulative dose? In Marks R, Plewig G (eds): Acne and Related Disorders, Cardiff, 1988. London, Dunitz, 1989, pp 203-206.
17. Jones DH, Cunliffe WJ: Remission rates in acne patients treated with various doses of 13-cis-retinoic acid (isotretinoin). Br J Dermatol 1984;111:123-125.
18. Jones DH, Cunliffe WJ: A follow-up study of 13-cis-retinoic acid therapy in cystic acne; in Cunliffe WJ, Miller AJ (eds): Retinoid Therapy. Lancaster, MTP Press, 1984, pp 241-251.
19. Cunliffe WJ, Jones DH, Pritlove J, Parkin D: Long-term benefit of isotretinoin in acne: clinical and laboratory studies; in Saurat JH (ed): Retinoids: New Trends in Research and Therapy. Basel, Karger, 1985, pp 242-251.